Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HTLV-I Infection”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Post-approval studies (Phase 4)Study completedNCT03226119
What this trial is testing

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 150
Not applicableStudy completedNCT01754311
What this trial is testing

Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1

Who this might be right for
HTLV-I Infections
University Hospital Center of Martinique 155
Not applicableStudy completedNCT01651819
What this trial is testing

Urological Physical Therapy in HTLV-1 With Urinary Symptoms

Who this might be right for
Tropical Spastic ParaparesisHTLV-1
Hospital Universitário Professor Edgard Santos 20
Testing effectiveness (Phase 2)WithdrawnNCT01620736
What this trial is testing

Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load

Who this might be right for
Human T-cell Leukemia Virus Type 1 Infection
Washington University School of Medicine
Early research (Phase 1)Study completedNCT05240612
What this trial is testing

A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)

Who this might be right for
HTLV-1-Associated Myelopathy (HAM)
Tanabe Pharma Corporation 15
Testing effectiveness (Phase 2)UnknownNCT04004819
What this trial is testing

Rituximab for HTLV-1-associated Myelopathy

Who this might be right for
HTLV-1-associated Myelopathy
First Affiliated Hospital of Fujian Medical University 100
Very early researchStudy completedNCT02655471
What this trial is testing

Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection

Who this might be right for
HTLV-I InfectionsTropical Spastic Paraparesis
Universidad Peruana Cayetano Heredia 10
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Very early researchStudy completedNCT01867320
What this trial is testing

Raltegravir for HAM/TSP

Who this might be right for
HTLV-I Infection
National Institute of Neurological Disorders and Stroke (NINDS) 19
Not applicableStudy completedNCT00097006
What this trial is testing

Retrovirus Epidemiology Donor Study-II (REDS-II)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+10 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Not applicableEnded earlyNCT00519181
What this trial is testing

Safety and Efficiency Study of Valproic Acid In HAM/TSP

Who this might be right for
HTLV-I-Associated Myelopathy
University Hospital Pierre Zobda-Quitman 19
Not applicableStudy completedNCT01050881
What this trial is testing

Notification of Donors With Positive Microbiology Markers

Who this might be right for
Human Immunodeficiency VirusHepatitis BHepatitis C+2 more
NHS Blood and Transplant 217
Large-scale testing (Phase 3)Ended earlyNCT03191526
What this trial is testing

KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)

Who this might be right for
HTLV-1 Associated Myelopathy
Kyowa Kirin Co., Ltd. 66
Testing effectiveness (Phase 2)Study completedNCT02631746
What this trial is testing

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+3 more
National Cancer Institute (NCI) 3
Not applicableLooking for participantsNCT05237245
What this trial is testing

Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)

Who this might be right for
Lymphoproliferation Induced by HTLV-1HTLV-1 Adult T-cell Lymphoma / LeukemiaHTLV-1 Infection
Assistance Publique - Hôpitaux de Paris 120
Not applicableStudy completedNCT03829709
What this trial is testing

Electromiography Study in the Respiratory Muscle Training in Human Lymphotropic Virus Type 1

Who this might be right for
HTLV-I Infections
Universidade Metodista de Piracicaba 20
Not applicableLooking for participantsNCT00001778
What this trial is testing

Evaluation of Patients With HAM/TSP

Who this might be right for
HTLV-I InfectionTropical Spastic Paraparesis
National Institute of Neurological Disorders and Stroke (NINDS) 750
Post-approval studies (Phase 4)Ended earlyNCT00854581
What this trial is testing

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

Who this might be right for
LymphomaPrecancerous/Nonmalignant Condition
University of Miami 13
Testing effectiveness (Phase 2)Study completedNCT00001941
What this trial is testing

Anti-Tac for Treatment of Leukemia

Who this might be right for
HTLV-I InfectionT Cell Leukemia
National Cancer Institute (NCI) 34
Load More Results